|
|
Office Locations:
|
Suite A, 60/F, Bank of China Tower
1 Garden Road
Central Hong Kong,
China
Phone: 852-2115-8380
Fax: 852-2115-8387
| |
|
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
|
Oceanpine Capital is an institutional growth equity investment company formed by seasoned entrepreneurs and sophisticated investors. The firm is rooted in China with 20 years of in-depth industry operational and business building experience, and invests in DeepTech, innovative growth companies in both TMT and healthcare sectors that are the driving force of the future economy in the New Norm. Deal types are early-growth and growth capital oriented, with the firm having a high operational focus and a dedicated portfolio management team.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
